PharmGKB Blog
Tuesday, December 11, 2018

New CPIC guideline: potent volatile anesthetic agents and succinylcholine in the context of RYR1 or CACNA1S genotypes

›
The CPIC Guidelines for  potent volatile anesthetic agents and succinylcholine in the context of   RYR1   or   CACNA1S   genotypes  is now ...
Friday, December 7, 2018

CPIC Dosing Guidelines for DPYD and Fluoropyrimidines Updated

›
An update to the CPIC dosing guidelines for DPYD and fluoropyrimidines has recently been added to the CPIC and PharmGKB websites. The mo...
Tuesday, December 4, 2018

New biogeographical groups in use at PharmGKB

›
Recent visitors to the PharmGKB website may have noticed a change in how we report racial and ethnicity information in our v...
Monday, December 3, 2018

New PharmGKB pathways for methylphenidate

›
PharmGKB released two new pathways for methylphenidate. Methylphenidate is a central nervous system stimulant used for the treatment of att...
Monday, November 19, 2018

CYP2D6*14A and *14B are updated to *114 and *14 based on the current PharmVar release

›
PharmGKB and CPIC revised the CYP2D6 allele names *14A and *14B to be in concordance with the latest major PharmVar release .  CYP2D6*14A...
Monday, November 5, 2018

Major PharmVar update released

›
PharmVar has announced the release of a major update to www.pharmvar.org . Notable new features include a revised haplotype naming system, ...
Friday, October 26, 2018

PharmGKB data used to establish a minimum genetic testing panel for psychiatry

›
The lack of st andardization of which genes or alleles should be included in pharmacogenetic testing panels is a major ...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.